The PI3K-AKT-mTOR pathway activates recovery from general anesthesia

Oncotarget

Volumn 7, Issue 27, 2016, Pages 40939-40952

  Zhang, Yun Hui ^a   Zhang, Jin ^b   Song, Jian Nan ^c   Xu, Xue ^a   Cai, Jin Song ^a   Zhou, Yang ^a   Gao, Jin Gui ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Shijiazhuang Obstetrics and Gynecology Hospital ^*  (China)

^c Chifeng Municipal Hospital   (China)

Author keywords

General anesthesia; Morris water maze; Pathology Section; PI3K AKT mTOR pathway; Recovery from general anesthesia; Righting reflex

Indexed keywords

KETAMINE; MTOR PROTEIN, RAT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; S6 KINASE; TARGET OF RAPAMYCIN KINASE;

ANIMAL; ANIMAL MODEL; CEREBROSPINAL FLUID; CONVALESCENCE; FEMALE; GENERAL ANESTHESIA; HIPPOCAMPUS; MALE; MEMORY; METABOLISM; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPATIAL LEARNING; SPRAGUE DAWLEY RAT;

ANESTHESIA, GENERAL; ANIMALS; FEMALE; HIPPOCAMPUS; KETAMINE; MALE; MEMORY; MODELS, ANIMAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SPATIAL LEARNING; TOR SERINE-THREONINE KINASES;

EID: 85019188781     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10172     Document Type: Article

References (48)

1. Flick RP, Katusic SK, Colligan RC, Wilder RT, Voigt RG, Olson MD, et al. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 2011;128:e1053-61.
2. Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med 2010;363:2638-50.
3. Nallasamy N, Tsao DY. Functional connectivity in the brain: Effects of anesthesia. Neuroscientist 2011;17:94-106.
4. Vricella LK, Louis JM, Mercer BM, Bolden N. Anesthesia complications during scheduled cesarean delivery for morbidly obese women. Am J Obstet Gynecol 2010;203:276 e1-5.
5. Evered L, Scott DA, Silbert B, Maruff P. Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg 2011;112:1179-85.
6. Alkire MT, Hudetz AG, Tononi G. Consciousness and anesthesia. Science 2008;322:876-80.
7. Krenk L, Rasmussen LS, Kehlet H. New insights into the pathophysiology of postoperative cognitive dysfunction. Acta Anaesthesiol Scand 2010;54:951-6.
8. Hawkins JL, Chang J, Palmer SK, Gibbs CP, Callaghan WM. Anesthesia-related maternal mortality in the united states: 1979-2002. Obstet Gynecol 2011;117:69-74.
9. Li G, Warner M, Lang BH, Huang L, Sun LS. Epidemiology of anesthesia-related mortality in the united states, 1999-2005. Anesthesiology 2009;110:759-65.
10. Porta C, Paglino C, Mosca A. Targeting pi3k/AKT/mtor signaling in cancer. Front Oncol 2014;4:64.
11. Johnson SM, Gulhati P, Rampy BA, Han Y, Rychahou PG, Doan HQ, et al. Novel expression patterns of pi3k/AKT/ mtor signaling pathway components in colorectal cancer. J Am Coll Surg 2010;210:767-76, 76-8.
12. King D, Yeomanson D, Bryant HE. Pi3king the lock: Targeting the pi3k/AKT/mtor pathway as a novel therapeutic strategy in neuroblastoma. J Pediatr Hematol Oncol 2015;37:245-51.
13. LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. Targeting the pi3k/AKT/mtor pathway: Effective combinations and clinical considerations. Drug Resist Updat 2008;11:32-50.
14. Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, et al. Targeting pi3k/AKT/mtor signaling pathway in the treatment of prostate cancer radioresistance. Crit Rev Oncol Hematol 2015;96:507-17.
15. Yap TA, Garrett MD, Walton MI, Raynaud F, de Bono JS, Workman P. Targeting the pi3k-AKT-mtor pathway: Progress, pitfalls, and promises. Curr Opin Pharmacol 2008;8:393-412.
16. Markman B, Dienstmann R, Tabernero J. Targeting the pi3k/AKT/mtor pathway-beyond rapalogs. Oncotarget 2010;1:530-43. doi: 10.18632/oncotarget.188.
17. Swiech L, Perycz M, Malik A, Jaworski J. Role of mtor in physiology and pathology of the nervous system. Biochim Biophys Acta 2008;1784:116-32.
18. Ojeda L, Gao J, Hooten KG, Wang E, Thonhoff JR, Dunn TJ, et al. Critical role of pi3k/AKT/gsk3beta in motoneuron specification from human neural stem cells in response to fgf2 and egf. PLoS One 2011;6:e23414.
19. Peltier J, O'Neill A, Schaffer DV. Pi3k/AKT and creb regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 2007;67:1348-61.
20. Hoeffer CA, Klann E. Mtor signaling: At the crossroads of plasticity, memory and disease. Trends Neurosci 2010;33:67-75.
21. Hou L, Klann E. Activation of the phosphoinositide 3-kinase-AKT-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 2004;24:6352-61.
22. Guide for the care and use of laboratory animals. Washington (DC), 1996
23. Rebuelto M, Ambros L, Waxman S, Montoya L. Chronobiological study of the pharmacological response of rats to combination ketamine-midazolam. Chronobiol Int 2004;21 (4-5):591-600.
24. Vorhees CV, Williams MT. Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006;1:848-58.
25. Hoet JJ, Ozanne S, Reusens B. Influences of pre- and postnatal nutritional exposures on vascular/endocrine systems in animals. Environ Health Perspect 2000;108 Suppl 3:563-8.
26. Wang C, Liu F, Patterson TA, Paule MG, Slikker W, Jr. Preclinical assessment of ketamine. CNS Neurosci Ther 2013;19:448-53.
27. Hong J, Qian T, Le Q, Sun X, Wu J, Chen J, et al. Ngf promotes cell cycle progression by regulating d-type cyclins via pi3k/akt and mapk/erk activation in human corneal epithelial cells. Mol Vis 2012;18:758-64.
28. Liu Z, Cai H, Zhang P, Li H, Liu H, Li Z. Activation of erk1/2 and pi3k/akt by igf-1 on gap-43 expression in drg neurons with excitotoxicity induced by glutamate in vitro. Cell Mol Neurobiol 2012;32:191-200.
29. Benfey BG. Function of myocardial alpha-adrenoceptors. Life Sci 1990;46:743-57.
30. Gomez RS, Guatimosim C, Gomez MV. Mechanism of action of volatile anesthetics: Role of protein kinase c. Cell Mol Neurobiol 2003;23:877-85.
31. Karar J, Maity A. Pi3k/AKT/mtor pathway in angiogenesis. Front Mol Neurosci 2011;4:51.
32. Chen A, Xiong LJ, Tong Y, Mao M. Neuroprotective effect of brain-derived neurotrophic factor mediated by autophagy through the pi3k/AKT/mtor pathway. Mol Med Rep 2013;8:1011-6.
33. Schulz R. A new paradigm: Cross talk of protein kinases during reperfusion saves life! Am J Physiol Heart Circ Physiol 2005;288:H1-2.
34. Polivka J, Jr., Janku F. Molecular targets for cancer therapy in the pi3k/AKT/mtor pathway. Pharmacol Ther 2014;142:164-75.
35. Perluigi M, Pupo G, Tramutola A, Cini C, Coccia R, Barone E, et al. Neuropathological role of pi3k/AKT/ mtor axis in down syndrome brain. Biochim Biophys Acta 2014;1842:1144-53.
36. Burris HA, 3rd. Overcoming acquired resistance to anticancer therapy: Focus on the pi3k/AKT/mtor pathway. Cancer Chemother Pharmacol 2013;71:829-42.
37. Bitting RL, Armstrong AJ. Targeting the pi3k/AKT/mtor pathway in castration-resistant prostate cancer. Endocr Relat Cancer 2013;20:R83-99.
38. Sharma D, Jelacic J, Chennuri R, Chaiwat O, Chandler W, Vavilala MS. Incidence and risk factors for perioperative hyperglycemia in children with traumatic brain injury. Anesth Analg 2009;108:81-9.
39. Yu M, Li W, Luo S, Zhang Y, Liu H, Gao Y, et al. Folic acid stimulation of neural stem cell proliferation is associated with altered methylation profile of pi3k/akt/creb. J Nutr Biochem 2014;25:496-502.
40. Lee JE, Lim MS, Park JH, Park CH, Koh HC. S6k promotes dopaminergic neuronal differentiation through pi3k/akt/ mtor-dependent signaling pathways in human neural stem cells. Mol Neurobiol 2015 41 Feliciano DM, Zhang S, Nasrallah CM, Lisgo SN, Bordey A. Embryonic cerebrospinal fluid nanovesicles carry evolutionarily conserved molecules and promote neural stem cell amplification. PLoS One 2014;9:e88810.
41. Zhang T, Guan H, Yang K. Keratinocyte growth factor promotes preadipocyte proliferation via an autocrine mechanism. J Cell Biochem 2010;109:737-46.
42. Wei H, Xie Z. Anesthesia, calcium homeostasis and alzheimer's disease. Curr Alzheimer Res 2009;6:30-5.
43. Thrane AS, Rangroo Thrane V, Zeppenfeld D, Lou N, Xu Q, Nagelhus EA, et al. General anesthesia selectively disrupts astrocyte calcium signaling in the awake mouse cortex. Proc Natl Acad Sci U S A 2012;109:18974-9.
44. L Uhrig SD, B Jarraya. Iconography: Cerebral mechanisms of general anesthesia [j]. Elsevier Masson
45. Boveroux P, Bonhomme V, Kirsch M, Noirhomme Q, Ledoux D, Hans G, et al. [contribution of functional neuroimaging studies to the understanding of the mechanisms of general anesthesia]. Rev Med Liege 2009;64 Spec No:36-41.
46. Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med 2010;363:2638-50.
47. Altun C, Borazan H, Sahin O, Gezginc K. Effects of anesthesia type on short-term postoperative cognitive function in obstetric patients following cesarean section. J Turk Ger Gynecol Assoc 2015;16:219-25.
48. Mason SE, Noel-Storr A, Ritchie CW. The impact of general and regional anesthesia on the incidence of post-operative cognitive dysfunction and post-operative delirium: A systematic review with meta-analysis. J Alzheimers Dis 2010;22 Suppl 3:67-79.